NAMS

NewAmsterdam Pharma Company N.V. Ordinary Shares

23.80

USD

+0.32

+1.34%

Mar 07, 15:59 UTC -5

Closed

After-Market

23.815

+0.02

+0.06%

NewAmsterdam Pharma Company N.V. Ordinary Shares Profile

About

NewAmsterdam Pharma Holding B.V. is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases. NewAmsterdam Pharma Holding B.V., formerly known as Frazier Lifesciences Acquisition Corporation, is based in MENLO PARK, Calif.

Info & Links

CEO

Michael Davidson

Headquarters

GOOIMEER 2-35
NARRDEN, P7 1411 DC, NETHERLANDS

Auditor

Deloitte Accountants B.V.

Share holders

30

Employees

29

NewAmsterdam Pharma Company N.V. Ordinary Shares Statistics

Valuation Measures

Market Capitalization²

2.62B

Enterprise Value

2.19B

Enterprise Value/EBITDA(ttm)

-11.91

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.62

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-2295.84%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-49.40%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

33.59M

Revenue Per Share(ttm)

0.36

Gross Profit(ttm)

33.59M

EBITDA(ttm)³

-184.06M

Net Income Available to Common(ttm)

-198.92M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-0.06

52-Week Change

13.77%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

92.39M

Dividend Yield

0.00%

Float⁴

74.37M

% Held by Insiders

19.50%

% Held by Institutions

89.89%

Balance Sheet

Total Cash(mrq)

422.73M

Total Cash Per Share(mrq)

4.58

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.08%

Quick Ratio(mrq)

10.61%

Book Value Per Share(mrq)

7.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.68

Free Cash Flow(ytd)

-159.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.